262 related articles for article (PubMed ID: 37505499)
81. The value of Korean, American, and Chinese ultrasound risk stratification systems combined with BRAF(V600E) mutation for detecting papillary thyroid carcinoma in cytologically indeterminate thyroid nodules.
Lin Y; Cheng Y; Zhang Y; Ren X; Li J; Shi H; Li Y; Luo Y; Wang H
Endocrine; 2024 May; 84(2):549-559. PubMed ID: 37940765
[TBL] [Abstract][Full Text] [Related]
82. Significance of FNAC, BRAF mutation, and intraoperative frozen section in surgical decision-making of thyroid nodules.
Zhu Z; Su C; Chen G; Wan F; Jin M; Duan X; Wang Y; Wang G
Diagn Cytopathol; 2023 Jul; 51(7):441-448. PubMed ID: 37042168
[TBL] [Abstract][Full Text] [Related]
83. The Genetic Duet of
Liu J; Liu R; Shen X; Zhu G; Li B; Xing M
J Nucl Med; 2020 Feb; 61(2):177-182. PubMed ID: 31375570
[No Abstract] [Full Text] [Related]
84. Preoperative Assessment of TERT Promoter Mutation on Thyroid Core Needle Biopsies Supports Diagnosis of Malignancy and Addresses Surgical Strategy.
Crescenzi A; Trimboli P; Modica DC; Taffon C; Guidobaldi L; Taccogna S; Rainer A; Trombetta M; Papini E; Zelano G
Horm Metab Res; 2016 Mar; 48(3):157-62. PubMed ID: 25951319
[TBL] [Abstract][Full Text] [Related]
85. Diagnostic utility of BRAFV600E mutation testing in thyroid nodules in elderly patients.
Guerra A; Di Crescenzo V; Garzi A; Cinelli M; Carlomagno C; Pepe S; Zeppa P; Tonacchera M; Vitale M
BMC Surg; 2013; 13 Suppl 2(Suppl 2):S37. PubMed ID: 24267957
[TBL] [Abstract][Full Text] [Related]
86. A multiplex technology platform for the rapid analysis of clinically actionable genetic alterations and validation for BRAF p.V600E detection in 1549 cytologic and histologic specimens.
Smith DL; Lamy A; Beaudenon-Huibregtse S; Sesboüé R; Laosinchai-Wolf W; Sabourin JC; Labourier E
Arch Pathol Lab Med; 2014 Mar; 138(3):371-8. PubMed ID: 23808402
[TBL] [Abstract][Full Text] [Related]
87. BRAF mutation analysis in thyroid nodules with indeterminate cytology: our experience on surgical management of patients with thyroid nodules from an area of borderline iodine deficiency.
Agretti P; Niccolai F; Rago T; De Marco G; Molinaro A; Scutari M; Di Cosmo C; Di Coscio G; Vitale M; Maccheroni M; Vitti P; Tonacchera M
J Endocrinol Invest; 2014 Oct; 37(10):1009-14. PubMed ID: 25194426
[TBL] [Abstract][Full Text] [Related]
88. [Preoperative molecular testing on fine-needle aspiration in precision management of thyroid cancer].
Song YT; Zhang B
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):58-61. PubMed ID: 30704174
[TBL] [Abstract][Full Text] [Related]
89. TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
Qasem E; Murugan AK; Al-Hindi H; Xing M; Almohanna M; Alswailem M; Alzahrani AS
Endocr Relat Cancer; 2015 Dec; 22(6):901-8. PubMed ID: 26354077
[TBL] [Abstract][Full Text] [Related]
90. BRAF V600E and TERT promoter mutations in paediatric and young adult papillary thyroid cancer and clinicopathological correlation.
Chakraborty D; Shakya S; Ballal S; Agarwal S; Bal C
J Pediatr Endocrinol Metab; 2020 Nov; 33(11):1465-1474. PubMed ID: 33027050
[TBL] [Abstract][Full Text] [Related]
91. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
Johnson SJ; Hardy SA; Roberts C; Bourn D; Mallick U; Perros P
Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615
[TBL] [Abstract][Full Text] [Related]
92. BRAFV600E mutation testing in fine needle aspirates of thyroid nodules: potential value of real-time PCR.
Kwak JY; Han KH; Yoon JH; Kim EK; Moon HJ; Kim YL; Park SJ; Choi JR
Ann Clin Lab Sci; 2012; 42(3):258-65. PubMed ID: 22964613
[TBL] [Abstract][Full Text] [Related]
93. Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules: A Prospective Study of
Cho YY; Park SY; Shin JH; Oh YL; Choe JH; Kim JH; Kim JS; Yim HS; Kim YL; Ki CS; Kim TH; Chung JH; Kim SW
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781560
[TBL] [Abstract][Full Text] [Related]
94. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.
Zimmermann AK; Camenisch U; Rechsteiner MP; Bode-Lesniewska B; Rössle M
Cancer Cytopathol; 2014 Jan; 122(1):48-58. PubMed ID: 24039206
[TBL] [Abstract][Full Text] [Related]
95. High-accuracy Detection of Preoperative Thyroid Nodules Using Combination of BRAF
Zhang Y; Zhang Z; Ma J; Pu J; Hou P; Yang Q
Arch Med Res; 2018 Aug; 49(6):365-372. PubMed ID: 30518486
[TBL] [Abstract][Full Text] [Related]
96. Digital droplet PCR TERT promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre-operative identification of high-risk cases.
Hysek M; Hellgren LS; Stenman A; Darai-Ramqvist E; Ljung E; Schliemann I; Condello V; Larsson C; Zedenius J; Jatta K; Juhlin CC
Diagn Cytopathol; 2023 Jun; 51(6):331-340. PubMed ID: 36870048
[TBL] [Abstract][Full Text] [Related]
97. Diagnostic value of fine needle aspiration BRAF(V600E) mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis.
Fnais N; Soobiah C; Al-Qahtani K; Hamid JS; Perrier L; Straus SE; Tricco AC
Hum Pathol; 2015 Oct; 46(10):1443-54. PubMed ID: 26232865
[TBL] [Abstract][Full Text] [Related]
98. Evaluation of the Anyplex BRAF V600E real-time detection assay using dual-priming oligonucleotide technology in fine-needle aspirates of thyroid nodules.
Choi R; Park KS; Kim JW; Ki CS
Ann Lab Med; 2015 Nov; 35(6):624-9. PubMed ID: 26354351
[TBL] [Abstract][Full Text] [Related]
99. Coexistence of
Rusinek D; Pfeifer A; Krajewska J; Oczko-Wojciechowska M; Handkiewicz-Junak D; Pawlaczek A; Zebracka-Gala J; Kowalska M; Cyplinska R; Zembala-Nozynska E; Chekan M; Chmielik E; Kropinska A; Lamch R; Jurecka-Lubieniecka B; Jarzab B; Czarniecka A
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200646
[No Abstract] [Full Text] [Related]
100. Utility of a multigene testing for preoperative evaluation of indeterminate thyroid nodules: A prospective blinded single center study in China.
Song Y; Xu G; Ma T; Zhu Y; Yu H; Yu W; Wei W; Wang T; Zhang B
Cancer Med; 2020 Nov; 9(22):8397-8405. PubMed ID: 32976686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
